EM2006F "Slaying the Hydra: Recurrent Clostridioides difficile infections" (IM GR-062620)

The purpose of this presentation is to acquaint the viewers with recent advances in the treatment and prevention of recurrent Clostridioides difficile infections (rCDI). The presentation will begin with a review of the pathogenesis and epidemiology of rCDI, followed by discussion of newer agents available to treat rCDI (fidaxomicin, bezlotoxumab), and will conclude with remarks on the current state of fecal microbiota transplantation (FMT), generally and at UT Southwestern Medical Center.

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Briefly review the pathogenesis of Clostridioides difficile infections (CDI).
  • Discuss the epidemiology and risk factors for recurrent Clostridioides difficile infections (rCDI).
  • Review pharmacological/biological interventions to treat and prevent rCDI.
  • Provide an overview of fecal microbiota transplantation (FMT) and other interventions designed to favorably alter the host microbiome to prevent rCDI.
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
06/29/2020
Course expires: 
07/31/2020
Cost:
$0.00
Rating: 
0

Photo: Jeffrey Tessier, M.D.Jeffrey Tessier, M.D.
Associate Professor of Internal Medicine
Division of Infectious Disease and Geographic Medicine

Available Credit

  • 1.00 AMA

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome